U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07477600) titled 'cfMSC Stem Cell Therapy Targeting COPD' on March 10.
Brief Summary: The primary objectives are to evaluate the safety and efficacy of infusion of fully characterized clonally derived fetal mesenchymal stem cells (cfMSCs) for the control of severe symptoms associated with moderate to severe chronic obstructive pulmonary disease.
Study Start Date: March 10
Study Type: INTERVENTIONAL
Condition:
Chronic Obstructive Pulmonary Disease (COPD)
Intervention:
BIOLOGICAL: clonal fetal MSCs
cfMSCs to treat Chronic Obstructive Pulmonary Disease
Recruitment Status: RECRUITING
Sponsor: Shenzhen Geno-Immune Medical Institute
Published by...